Metastases, Brain
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer (NCT00820222) | Novartis Pharmaceuticals | 2009-04-14 |
Track Metastases, Brain automatically
Every clearance here is in the API, with alerts when new ones post.